| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
5
5
1
4
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
B-
(Buy)
|
#1 in Emerging Markets Bond
U.S. News evaluated 77 Emerging Markets Bond Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
Performance
The fund has returned 17.88 percent over the past year, 16.50 percent over the past three years, 12.46 percent over the past five years, and 13.62 percent over the past decade.
| Trailing Returns | Updated 04.30.2013 |
|---|---|
| Year to date | 2.8% |
| 1 Year | 17.9% |
| 3 Years (Annualized) | 16.5% |
| 5 Years (Annualized) | 12.5% |
| 10 Years (Annualized) | 13.6% |
Summary
The investment seeks total return in excess of that of its benchmark, the J.P. Morgan EMBI Global. The fund invests primarily in external sovereign and quasi-sovereign debt instruments of emerging countries. It normally invests directly and indirectly at least 80% of its assets in debt investments tied economically to emerging countries. The fund typically gains its investment exposure by purchasing debt instruments or by using derivatives, typically credit default swaps. It is non-diversified.
Fees
Fees are Low compared to funds in the same category.
GMO Emerging Country Debt Fund has an expense ratio of 0.64 percent.
Risk
Risk is High compared to funds in the same category according to Morningstar.
